Leiden, Netherlands

Dmitri V Filippov

This inventor holds 1 USPTO granted patent. Top assignees: Academisch Ziekenhuis Leiden, Leiden University. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dmitri V Filippov. Retrieved from https://idiyas.com/inventor/dmitri-v-filippov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dmitri V Filippov: Innovator in Immunology

Introduction

Dmitri V Filippov is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of immunology through his innovative research and development of adjuvant compounds. His work focuses on enhancing immune responses, which is crucial for treating various diseases.

Latest Patents

Dmitri holds a patent for "Peptide-containing adjuvant compounds having peg spacers." This patent describes adjuvant compounds and their conjugates that comprise peptide antigens or other immunomodulatory moieties. The methods outlined in the patent aim to modulate immune responses in subjects in need, as well as treat cancer, viral, or bacterial infections by administering these adjuvant compounds or conjugates.

Career Highlights

Throughout his career, Dmitri has worked with esteemed institutions such as Universiteit Leiden and Academisch Ziekenhuis Leiden. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Dmitri has collaborated with Geoffroy P P Gential, further enhancing the impact of his work in immunology.

Conclusion

Dmitri V Filippov's innovative contributions to immunology, particularly through his patented adjuvant compounds, highlight his role as a significant inventor in the field. His work continues to influence the development of treatments for various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…